298 related articles for article (PubMed ID: 32035187)
21. Early toxicity and patient reported quality-of-life in patients receiving proton therapy for localized prostate cancer: a single institutional review of prospectively recorded outcomes.
Lee HJ; Macomber MW; Spraker MB; Bowen SR; Hippe DS; Fung A; Russell KJ; Laramore GE; Rengan R; Liao J; Apisarnthanarax S; Zeng J
Radiat Oncol; 2018 Sep; 13(1):179. PubMed ID: 30223877
[TBL] [Abstract][Full Text] [Related]
22. Feasibility of and rectal dosimetry improvement with the use of SpaceOAR® hydrogel for dose-escalated prostate cancer radiotherapy.
van Gysen K; Kneebone A; Alfieri F; Guo L; Eade T
J Med Imaging Radiat Oncol; 2014 Aug; 58(4):511-6. PubMed ID: 24580893
[TBL] [Abstract][Full Text] [Related]
23. Intensity modulated proton and photon therapy for early prostate cancer with or without transperineal injection of a polyethylen glycol spacer: a treatment planning comparison study.
Weber DC; Zilli T; Vallee JP; Rouzaud M; Miralbell R; Cozzi L
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e311-8. PubMed ID: 22999271
[TBL] [Abstract][Full Text] [Related]
24. Influence of hydrogel spacer placement with prostate brachytherapy on rectal and urinary toxicity.
Teyateeti A; Grossman C; Kollmeier MA; Fiasconaro M; Hopkins M; McBride S; Gorovets D; Shasha D; Cohen G; Zhang Z; Lesser DJ; Damato A; Zelefsky MJ
BJU Int; 2022 Mar; 129(3):337-344. PubMed ID: 34388295
[TBL] [Abstract][Full Text] [Related]
25. Dosimetric feasibility of neurovascular bundle-sparing stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer to preserve erectile function.
Hwang ME; Mayeda M; Shaish H; Elliston CD; Spina CS; Wenske S; Deutsch I
Br J Radiol; 2021 Mar; 94(1119):20200433. PubMed ID: 33586999
[TBL] [Abstract][Full Text] [Related]
26. Continued Benefit to Rectal Separation for Prostate Radiation Therapy: Final Results of a Phase III Trial.
Hamstra DA; Mariados N; Sylvester J; Shah D; Karsh L; Hudes R; Beyer D; Kurtzman S; Bogart J; Hsi RA; Kos M; Ellis R; Logsdon M; Zimberg S; Forsythe K; Zhang H; Soffen E; Francke P; Mantz C; Rossi P; DeWeese T; Daignault-Newton S; Fischer-Valuck BW; Chundury A; Gay H; Bosch W; Michalski J
Int J Radiat Oncol Biol Phys; 2017 Apr; 97(5):976-985. PubMed ID: 28209443
[TBL] [Abstract][Full Text] [Related]
27. The impact of a rectal hydrogel spacer on dosimetric and toxicity outcomes among patients undergoing combination therapy with external beam radiotherapy and low-dose-rate brachytherapy.
Nehlsen AD; Sindhu KK; Moshier E; Sfakianos JP; Stock RG
Brachytherapy; 2021; 20(2):296-301. PubMed ID: 33199175
[TBL] [Abstract][Full Text] [Related]
28. Acute patient-reported bowel quality of life and rectal bleeding with the combination of prostate external beam radiation, low-dose-rate brachytherapy boost, and SpaceOAR.
Patel AK; Houser C; Benoit R; Smith RP; Beriwal S
Brachytherapy; 2020; 19(4):477-483. PubMed ID: 32331976
[TBL] [Abstract][Full Text] [Related]
29. Increasing rectum-prostate distance using a hydrogel spacer to reduce radiation exposure during proton beam therapy for prostate cancer.
Narukawa T; Aibe N; Tsujimoto M; Shiraishi T; Kimoto T; Suzuki G; Ueda T; Fujihara A; Yamazaki H; Ukimura O
Sci Rep; 2023 Oct; 13(1):18319. PubMed ID: 37884786
[TBL] [Abstract][Full Text] [Related]
30. Ion therapy of prostate cancer: daily rectal dose reduction by application of spacer gel.
Rucinski A; Brons S; Richter D; Habl G; Debus J; Bert C; Haberer T; Jäkel O
Radiat Oncol; 2015 Feb; 10():56. PubMed ID: 25886457
[TBL] [Abstract][Full Text] [Related]
31. Quality of Life After Radiation Therapy for Prostate Cancer With a Hydrogel Spacer: 5-Year Results.
Pinkawa M; Berneking V; Schlenter M; Krenkel B; Eble MJ
Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):374-377. PubMed ID: 28871986
[TBL] [Abstract][Full Text] [Related]
32. Quality of life and toxicity from passively scattered and spot-scanning proton beam therapy for localized prostate cancer.
Pugh TJ; Munsell MF; Choi S; Nguyen QN; Mathai B; Zhu XR; Sahoo N; Gillin M; Johnson JL; Amos RA; Dong L; Mahmood U; Kuban DA; Frank SJ; Hoffman KE; McGuire SE; Lee AK
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):946-53. PubMed ID: 24139077
[TBL] [Abstract][Full Text] [Related]
33. [Dosimetric impact of hydrogel spacer use for stereotactic body radiotherapy of localised prostate cancer].
Ung M; Bossi A; Abbassi L; Vautier J; Anthonipillai V; Chevé M; Blanchard P
Cancer Radiother; 2021 May; 25(3):237-241. PubMed ID: 33419606
[TBL] [Abstract][Full Text] [Related]
34. A Multi-Institutional Phase 2 Trial of High-Dose SAbR for Prostate Cancer Using Rectal Spacer.
Folkert MR; Zelefsky MJ; Hannan R; Desai NB; Lotan Y; Laine AM; Kim DWN; Neufeld SH; Hornberger B; Kollmeier MA; McBride S; Ahn C; Roehrborn C; Timmerman RD
Int J Radiat Oncol Biol Phys; 2021 Sep; 111(1):101-109. PubMed ID: 33753140
[TBL] [Abstract][Full Text] [Related]
35. Impact of mean rectal dose on late rectal bleeding after conformal radiotherapy for prostate cancer: dose-volume effect.
Zapatero A; García-Vicente F; Modolell I; Alcántara P; Floriano A; Cruz-Conde A; Torres JJ; Pérez-Torrubia A
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1343-51. PubMed ID: 15275719
[TBL] [Abstract][Full Text] [Related]
36. Improved rectal dosimetry with the use of SpaceOAR during high-dose-rate brachytherapy.
Wu SY; Boreta L; Wu A; Cheung JP; Cunha JAM; Shinohara K; Chang AJ
Brachytherapy; 2018; 17(2):259-264. PubMed ID: 29203149
[TBL] [Abstract][Full Text] [Related]
37. Rectal toxicity after proton therapy for prostate cancer: an analysis of outcomes of prospective studies conducted at the university of Florida Proton Therapy Institute.
Colaco RJ; Hoppe BS; Flampouri S; McKibben BT; Henderson RH; Bryant C; Nichols RC; Mendenhall WM; Li Z; Su Z; Morris CG; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):172-81. PubMed ID: 25442338
[TBL] [Abstract][Full Text] [Related]
38. Rectal spacer hydrogel in 1.5T MR-guided and daily adapted SBRT for prostate cancer: dosimetric analysis and preliminary patient-reported outcomes.
Alongi F; Rigo M; Figlia V; Cuccia F; Giaj-Levra N; Nicosia L; Ricchetti F; Vitale C; Sicignano G; De Simone A; Naccarato S; Ruggieri R; Mazzola R
Br J Radiol; 2021 Jan; 94(1117):20200848. PubMed ID: 33095659
[TBL] [Abstract][Full Text] [Related]
39. Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: further evidence for a significant dose effect.
Lee WR; Hanks GE; Hanlon AL; Schultheiss TE; Hunt MA
Int J Radiat Oncol Biol Phys; 1996 May; 35(2):251-7. PubMed ID: 8635930
[TBL] [Abstract][Full Text] [Related]
40. Rectal spacing, prostate coverage, and periprocedural outcomes after hydrogel spacer injection during low-dose-rate brachytherapy implantation.
Kahn J; Dahman B; McLaughlin C; Kapoor P; Kapoor R; Harris E; Sharma M; Schutzer M; Moghanaki D
Brachytherapy; 2020; 19(2):228-233. PubMed ID: 32085930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
